SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 28 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $984,000 | -24.9% | 4,118,402 | 0.0% | 0.04% | -37.3% |
| Q1 2018 | $1,311,000 | -37.3% | 4,118,402 | 0.0% | 0.07% | -38.5% |
| Q4 2017 | $2,092,000 | -45.6% | 4,118,402 | 0.0% | 0.11% | -2.7% |
| Q3 2017 | $3,843,000 | +65.0% | 4,118,402 | 0.0% | 0.11% | -22.8% |
| Q2 2017 | $2,329,000 | -10.3% | 4,118,402 | 0.0% | 0.14% | +12.4% |
| Q1 2017 | $2,597,000 | -17.3% | 4,118,402 | 0.0% | 0.13% | -18.4% |
| Q4 2016 | $3,141,000 | -41.4% | 4,118,402 | +32.1% | 0.16% | -63.5% |
| Q3 2016 | $5,364,000 | -4.4% | 3,118,402 | 0.0% | 0.43% | +18.3% |
| Q2 2016 | $5,613,000 | -43.5% | 3,118,402 | -25.9% | 0.37% | -29.8% |
| Q1 2016 | $9,932,000 | +3.1% | 4,208,500 | 0.0% | 0.52% | +27.7% |
| Q4 2015 | $9,637,000 | +0.9% | 4,208,500 | 0.0% | 0.41% | +29.9% |
| Q3 2015 | $9,553,000 | -6.5% | 4,208,500 | +17.4% | 0.31% | +52.4% |
| Q2 2015 | $10,213,000 | +30.1% | 3,583,500 | 0.0% | 0.21% | +11.4% |
| Q1 2015 | $7,848,000 | +50.0% | 3,583,500 | 0.0% | 0.18% | +49.2% |
| Q4 2014 | $5,232,000 | +9.9% | 3,583,500 | +34.0% | 0.12% | -13.3% |
| Q3 2014 | $4,762,000 | +3.5% | 2,675,000 | 0.0% | 0.14% | +19.2% |
| Q2 2014 | $4,601,000 | -33.1% | 2,675,000 | 0.0% | 0.12% | -54.0% |
| Q1 2014 | $6,875,000 | +68.0% | 2,675,000 | 0.0% | 0.26% | +56.3% |
| Q4 2013 | $4,093,000 | +16.0% | 2,675,000 | +27.4% | 0.17% | +25.6% |
| Q3 2013 | $3,528,000 | -2.3% | 2,100,000 | 0.0% | 0.13% | -32.8% |
| Q2 2013 | $3,612,000 | – | 2,100,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|